MedPath
HSA Approval

GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML

SIN15887P

GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML

GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML

February 20, 2020

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION CONCENTRATE

INTRAVENOUS

Medical Information

‎L01BC05

x‎l 01 bc 05

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Oncology Limited

Active Ingredients

Gemcitabine Hydrochloride 43.2668mg/ml eqv to Gemcitabine

38mg/ml

Gemcitabine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.